Liquidia Corp — Director's Dealing 2024

Jan 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2024-01-11

Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-11	Common Stock	A	221338	—	Acquired	862143	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-11	Performance Stock Units	$	A	221338	Acquired		Common Stock (221338)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46595	Indirect
Common Stock	1541667	Indirect

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2: 25% of the RSUs shall vest on January 11, 2025 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter.

F3: Includes 5,384 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

F4: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.

F5: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.

F6: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.

F7: On January 11, 2024, the Reporting Person was granted 221,338 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer.